CHU Nantes — Nantes, France

Public research footprint of CHU Nantes, compiled from the ClinicalTrials.gov public registry.

704

Registered studies

284

Active

184

Recruiting now

304

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Prostatic Neoplasms, Castration-Resistant · Leukemia, Lymphocytic, Chronic, B-Cell · Non-small Cell Lung Cancer

Recently updated registry entries

NCT05063565 — TheraSphere With Durvalumab and Tremelimumab for HCC (Active Not Recruiting)
NCT06544616 — A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease (Active Not Recruiting)
NCT07367100 — A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Nantes?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.